Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein

References

• Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology132, 2087–2102 (2007).
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology132, 2208–2225 (2007).
   PubMed Web of Science ®Google Scholar
• Chen H. Cellular inflammatory responses: novel insights for obesity and insulin resistance. Pharmacol. Res.22, 22 (2006).
   Google Scholar
• Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology132, 2169–2180 (2007).
   PubMed Web of Science ®Google Scholar
• Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia40, 1286–1292 (1997).
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Williams K, Festa A et al. Elevations in markers of liver injury and risk of Type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes53, 2623–2632 (2004).
   PubMed Web of Science ®Google Scholar
• Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS. C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care26, 2323–2328 (2003).
   PubMed Web of Science ®Google Scholar
• Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation108, 2957–2963 (2003).
   PubMed Web of Science ®Google Scholar
• Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet366, 1809–1820 (2005).
   PubMed Web of Science ®Google Scholar
• Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr. Diab. Rep.4, 194–198 (2004).
   Google Scholar
• Yuan M, Konstantopoulos N, Lee J et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science293, 1673–1677 (2001).
   PubMed Web of Science ®Google Scholar
• Freeman DJ, Norrie J, Sattar N et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation103, 357–362 (2001).
   PubMed Web of Science ®Google Scholar
• Muhlestein JB, May HT, Jensen JR et al. The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study. J. Am. Coll. Cardiol.48, 396–401 (2006).
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin–angiotensin system and cardiovascular risk. Lancet369, 1208–1219 (2007).
   PubMed Web of Science ®Google Scholar
• Mohanty P, Aljada A, Ghanim H et al. Evidence for a potent antiinflammatory effect of rosiglitazone. J. Clin. Endocrinol. Metab.89, 2728–2735 (2004).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science259, 87–91 (1993).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes54(Suppl. 2), S73–S78 (2005).
   PubMed Web of Science ®Google Scholar
• Kaneto H, Nakatani Y, Miyatsuka T et al. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat. Med.10, 1128–1132 (2004).
   PubMed Web of Science ®Google Scholar
• Arkan MC, Hevener AL, Greten FR et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat. Med.11, 191–198 (2005).
   PubMed Web of Science ®Google Scholar
• Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell. Biol.24, 5434–5446 (2004).
   PubMed Web of Science ®Google Scholar
• Shi H, Tzameli I, Bjorbaek C, Flier JS. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J. Biol. Chem.279, 34733–34740 (2004).
   PubMed Web of Science ®Google Scholar
• Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat. Med.10, 734–738 (2004).
   PubMed Web of Science ®Google Scholar
• Michell GR, BJ, van Denderen BJ et al. Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab.4, 465–474 (2006).
   Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol.6, 772–783 (2006).
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol.115, 911–919 (2005).
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest.112, 1796–1808 (2003).
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest.112, 1821–1830 (2003).
   PubMed Web of Science ®Google Scholar
• Curat CA, Miranville A, Sengenes C et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes53, 1285–1292 (2004).
   PubMed Web of Science ®Google Scholar
• Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res.46, 2347–2355 (2005).
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy4, 281–286 (2005).
   PubMedGoogle Scholar
• Charriere G, Cousin B, Arnaud E et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem.278, 850–9855 (2003).
   Google Scholar
• Kamei N, Tobe K, Suzuki R et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem.281, 26602–26614 (2006).
   PubMed Web of Science ®Google Scholar
• Kanda H, Tateya S, Tamori Y et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest.116, 1494–1505 (2006).
   PubMed Web of Science ®Google Scholar
• Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. (2007).
   Google Scholar
• Pou KM, Massaro JM, Hoffmann U et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation116, 1234–1241 (2007).
   PubMed Web of Science ®Google Scholar
• Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun.257, 79–83 (1999).
   PubMed Web of Science ®Google Scholar
• Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem.268, 10425–10432 (1993).
   PubMed Web of Science ®Google Scholar
• Goetz DH, Willie ST, Armen RS, Bratt T, Borregaard N, Strong RK. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry39, 1935–1941 (2000).
   PubMed Web of Science ®Google Scholar
• Bratt T, Ohlson S, Borregaard N. Interactions between neutrophil gelatinase-associated lipocalin and natural lipophilic ligands. Biochim. Biophys. Acta1472, 262–269 (1999).
   Google Scholar
• Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta1482, 272–283 (2000).
   PubMed Web of Science ®Google Scholar
• Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim. Biophys. Acta1482, 9–24 (2000).
   PubMed Web of Science ®Google Scholar
• Chu ST, Huang HL, Chen JM, Chen YH. Demonstration of a glycoprotein derived from the 24p3 gene in mouse uterine luminal fluid. Biochem. J.316(Pt 2), 545–550 (1996).
   Google Scholar
• Rudd PM, Mattu TS, Masure S et al. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. Biochemistry38, 13937–13950 (1999).
   Google Scholar
• Hraba-Renevey S, Turler H, Kress M, Salomon C, Weil R. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene4, 601–608 (1989).
   PubMed Web of Science ®Google Scholar
• Flo TH, Smith KD, Sato S et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature432, 917–921 (2004).
   PubMed Web of Science ®Google Scholar
• Fischbach MA, Lin H, Zhou L et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc. Natl Acad. Sci. USA103, 16502–16507 (2006).
   PubMed Web of Science ®Google Scholar
• Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest.115, 610–621 (2005).
   PubMed Web of Science ®Google Scholar
• Berger T, Togawa A, Duncan GS et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA103, 1834–1839 (2006).
   PubMed Web of Science ®Google Scholar
• Playford RJ, Belo A, Poulsom R et al. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology131, 809–817 (2006).
   Google Scholar
• Tong Z, Wu X, Kehrer JP. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochem. J.372, 203–210 (2003).
   Google Scholar
• Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, Kehrer JP. Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem. J.391, 441–448 (2005).
   PubMed Web of Science ®Google Scholar
• Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett.579, 773–777 (2005).
   PubMed Web of Science ®Google Scholar
• Devireddy LR, Gazin C, Zhu X, Green MR. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell123, 1293–1305 (2005).
   PubMed Web of Science ®Google Scholar
• Cowland JB, Sorensen OE, Sehested M, Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 β, but not by TNF-α. J. Immunol.171, 6630–6639 (2003).
   PubMed Web of Science ®Google Scholar
• Meheus LA, Fransen LM, Raymackers JG et al. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J. Immunol.151, 1535–1547 (1993).
   PubMed Web of Science ®Google Scholar
• Pawluczyk IZ, Furness PN, Harris KP. Macrophage-induced rat mesangial cell expression of the 24p3-like protein α-2-microglobulin-related protein. Biochim. Biophys. Acta1645, 218–227 (2003).
   Google Scholar
• Vizzardelli C, Pavelka N, Luchini A et al. Effects of dexamethazone on LPS-induced activation and migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. Eur. J. Immunol.36, 1504–1515 (2006).
   Google Scholar
• Bu DX, Hemdahl AL, Gabrielsen A et al. Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-κB. Am. J. Pathol.169, 2245–2253 (2006).
   PubMed Web of Science ®Google Scholar
• Cowland JB, Muta T, Borregaard N. IL-1β-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IκB-ζ. J. Immunol.176, 5559–5566 (2006).
   PubMed Web of Science ®Google Scholar
• Draper DW, Bethea HN, He YW. Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococci. Immunol. Lett.102, 202–214 (2006).
   Google Scholar
• Anwaar I, Gottsater A, Ohlsson K, Mattiasson I, Lindgarde F. Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia. Cerebrovasc. Dis.8, 310–317 (1998).
   PubMed Web of Science ®Google Scholar
• Falke P, Elneihoum AM, Ohlsson K. Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebrovasc. Dis.10, 97–101 (2000).
   Google Scholar
• Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet365, 1231–1238 (2005).
   PubMed Web of Science ®Google Scholar
• Schaub S, Mayr M, Honger G et al. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation84, 104–112 (2007).
   PubMed Web of Science ®Google Scholar
• Trachtman H, Christen E, Cnaan A et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr. Nephrol.21, 989–994 (2006).
   PubMed Web of Science ®Google Scholar
• Liu Q, Nilsen-Hamilton, M. Identification of a new acute phase protein. J. Biol. Chem.270, 22565–22570 (1995).
   PubMed Web of Science ®Google Scholar
• Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim. Biophys. Acta1482, 298–307 (2000).
   PubMed Web of Science ®Google Scholar
• Shen F, Ruddy MJ, Plamondon P, Gaffen SL. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-α-induced genes in bone cells. J. Leukoc. Biol.77, 388–399 (2005).
   PubMed Web of Science ®Google Scholar
• Aigner F, Maier HT, Schwelberger HG et al. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am. J. Transplant.7, 779–788 (2007).
   PubMed Web of Science ®Google Scholar
• Hemdahl AL, Gabrielsen A, Zhu C et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler. Thromb. Vasc. Biol.26, 136–142 (2006).
   PubMed Web of Science ®Google Scholar
• Faber K, Axler O, Dahlback B, Nielsen LB. Characterization of apoM in normal and genetically modified mice. J. Lipid Res.45, 1272–1278 (2004).
   PubMed Web of Science ®Google Scholar
• Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem.276, 37258–37265 (2001).
   PubMed Web of Science ®Google Scholar
• Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke27, 1734–1738 (1996).
   PubMed Web of Science ®Google Scholar
• Elneihoum AM, Falke P, Hedblad B, Lindgarde F, Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis131, 79–84 (1997).
   PubMed Web of Science ®Google Scholar
• Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J. Biol. Chem.276, 42077–42083 (2001).
   PubMed Web of Science ®Google Scholar
• Kratchmarova I, Kalume DE, Blagoev B et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics1, 213–222 (2002).
   PubMed Web of Science ®Google Scholar
• Baudry A, Yang ZZ, Hemmings BA. PKBα is required for adipose differentiation of mouse embryonic fibroblasts. J. Cell. Sci.119, 889–897 (2006).
   PubMed Web of Science ®Google Scholar
• Wang Y, Lam KS, Kraegen EW et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin. Chem.53, 34–41 (2007).
   PubMed Web of Science ®Google Scholar
• Yan QW, Yang Q, Mody N et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes56(10), 2533–2540 (2007).
   PubMed Web of Science ®Google Scholar
• Jayaraman A, Roberts KA, Yoon J et al. Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1β: a proteomic analysis. Biotechnol. Bioeng.91, 502–515 (2005).
   PubMedGoogle Scholar
• Sweetser DA, Birkenmeier EH, Klisak IJ et al. The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships. J. Biol. Chem.262, 16060–16071 (1987).
   PubMed Web of Science ®Google Scholar
• Boord JB, Fazio S, Linton MF. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr. Opin. Lipidol.13, 141–147 (2002).
   PubMed Web of Science ®Google Scholar
• Bernlohr DA Simpson MA, Hertzel AV et al. Intracellular lipid-binding proteins and their genes. Annu. Rev. Nutr.17, 277–303 (1997).
   PubMed Web of Science ®Google Scholar
• Flower DR. The lipocalin protein family: structure and function. Biochem. J.318(Pt 1), 1–14 (1996).
   PubMed Web of Science ®Google Scholar
• Bonen A, Luiken JJ, Liu S et al. Palmitate transport and fatty acid transporters in red and white muscles. Am. J. Physiol.275, E471–E478 (1998).
   Google Scholar
• Ho SY, Storch J. Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells. Am. J. Physiol. Cell. Physiol.281, C1106–1117 (2001).
   PubMed Web of Science ®Google Scholar
• Makowski L, Hotamisligil GS. Fatty acid binding proteins – the evolutionary crossroads of inflammatory and metabolic responses. J. Nutr.134, S2464–S2468 (2004).
   PubMed Web of Science ®Google Scholar
• Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by Toll-like receptor agonists. Arterioscler. Thromb. Vasc. Biol.25, 1220–1224 (2005).
   PubMed Web of Science ®Google Scholar
• Pelton PD, Zhou L, Demarest KT, Burris TP. PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem. Biophys. Res. Commun.261, 456–458 (1999).
   PubMed Web of Science ®Google Scholar
• Matarese V, Bernlohr DA. Purification of murine adipocyte lipid-binding protein. Characterization as a fatty acid- and retinoic acid-binding protein. J. Biol. Chem.263, 14544–14551 (1988).
   PubMedGoogle Scholar
• Veerkamp JH, van Moerkerk HT, Prinsen CF, van Kuppevelt TH. Structural and functional studies on different human FABP types. Mol. Cell. Biochem.192, 137–142 (1999).
   PubMed Web of Science ®Google Scholar
• Simpson MA, LiCata VJ, Ribarik Coe N, Bernlohr DA. Biochemical and biophysical analysis of the intracellular lipid binding proteins of adipocytes. Mol. Cell. Biochem.192, 33–40 (1999).
   Google Scholar
• Amri EZ, Bertrand B, Ailhaud G, Grimaldi P. Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J. Lipid Res.32, 1449–1456 (1991).
   PubMed Web of Science ®Google Scholar
• Distel RJ, Robinson GS, Spiegelman BM. Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms. J. Biol. Chem.267, 5937–5941 (1992).
   PubMedGoogle Scholar
• Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription? Biochem. Pharmacol.64, 893–901 (2002).
   PubMed Web of Science ®Google Scholar
• Schachtrup C, Emmler T, Bleck B, Sandqvist A, Spener F. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem. J.382, 239–245 (2004).
   PubMed Web of Science ®Google Scholar
• Liu J, Farmer SR. Regulating the balance between peroxisome proliferator-activated receptor γ and β-catenin signaling during adipogenesis. A glycogen synthase kinase 3β phosphorylation-defective mutant of β-catenin inhibits expression of a subset of adipogenic genes. J. Biol. Chem.279, 45020–45027 (2004).
   PubMed Web of Science ®Google Scholar
• Coe NR, Simpson MA, Bernlohr DA. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J. Lipid Res.40, 967–972 (1999).
   PubMed Web of Science ®Google Scholar
• Scheja L, Makowski L, Uysal KT et al. Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes48, 1987–1994 (1999).
   PubMed Web of Science ®Google Scholar
• Shen WJ, Sridhar K, Bernlohr DA, Kraemer FB. Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein. Proc. Natl Acad. Sci. USA96, 5528–5532 (1999).
   PubMed Web of Science ®Google Scholar
• Shen WJ, Liang Y, Hong R et al. Characterization of the functional interaction of adipocyte lipid-binding protein with hormone-sensitive lipase. J. Biol. Chem.276, 49443–49448 (2001).
   Google Scholar
• Fu Y, Luo L, Luo N, Garvey WT. Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis188, 102–111 (2006).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science274, 1377–1379 (1996).
   PubMed Web of Science ®Google Scholar
• Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology141, 3388–3396 (2000).
   PubMed Web of Science ®Google Scholar
• Krieg P, Feil S, Furstenberger G, Bowden GT. Tumor-specific overexpression of a novel keratinocyte lipid-binding protein. Identification and characterization of a cloned sequence activated during multistage carcinogenesis in mouse skin. J. Biol. Chem.268, 17362–17369 (1993).
   PubMed Web of Science ®Google Scholar
• Maeda K, Cao H, Kono K et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab.1, 107–119 (2005).
   PubMed Web of Science ®Google Scholar
• Sulsky R, Magnin DR, Huang Y et al. Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorg. Med. Chem. Lett.17, 3511–3515 (2007).
   PubMedGoogle Scholar
• Furuhashi M, Tuncman G, Gorgun CZ et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature447, 959–965 (2007).
   PubMed Web of Science ®Google Scholar
• Makowski L, Boord JB, Maeda K et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med.7, 699–705 (2001).
   PubMed Web of Science ®Google Scholar
• Boord JB, Maeda K, Makowski L et al. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol.22, 1686–1691 (2002).
   PubMed Web of Science ®Google Scholar
• Boord JB, Maeda K, Makowski L et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation110, 1492–1498 (2004).
   PubMed Web of Science ®Google Scholar
• Layne MD, Patel A, Chen YH et al. Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J.15, 2733–2735 (2001).
   Google Scholar
• Fu Y, Luo N, Lopes-Virella MF. Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J. Lipid Res.41, 2017–2023 (2000).
   Google Scholar
• Llaverias G, Noe V, Penuelas S et al. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem. Biophys. Res. Commun.318, 265–274 (2004).
   PubMed Web of Science ®Google Scholar
• Fu Y, Luo N, Lopes-Virella MF, Garvey WT. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis165, 259–269 (2002).
   PubMed Web of Science ®Google Scholar
• Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities. J. Biol. Chem.280, 12888–12895 (2005).
   PubMed Web of Science ®Google Scholar
• Shum BO, Mackay CR, Gorgun CZ et al. The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J. Clin. Invest.116, 2183–2192 (2006).
   PubMedGoogle Scholar
• Reynolds JM, Liu Q, Brittingham KC et al. Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis. J. Immunol.179, 313–321 (2007).
   Google Scholar
• Xu A, Wang Y, Xu JY et al. Adipocyte fatty acid binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem.52, 405–413 (2006).
   PubMed Web of Science ®Google Scholar
• Stejskal D, Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur. J. Clin. Invest.36, 621–625 (2006).
   PubMed Web of Science ®Google Scholar
• Mohlig M, Weickert MO, Ghadamgadai E et al. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur. J. Endocrinol.157, 195–200 (2007).
   PubMed Web of Science ®Google Scholar
• Haider DG, Schindler K, Bohdjalian A et al. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes. Metab.9, 761–763 (2007).
   PubMedGoogle Scholar
• Xu A, Tso AW, Cheung BM et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation115, 1537–1543 (2007).
   PubMed Web of Science ®Google Scholar
• Tso AW, Xu A, Sham PC et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of Type 2 diabetes – a 10-year prospective study in Chinese. Diabetes Care30(10), 2667–2672 (2007).
   PubMed Web of Science ®Google Scholar
• Yeung DC, Xu A, Cheung CW et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol.27, 1796–1802 (2007).
   PubMed Web of Science ®Google Scholar
• Mora S, Blumenthal RS, Yanek LR et al. Elevated C-reactive protein in high-risk asymptomatic individuals is strongly associated with the metabolic syndrome. J. Am. Coll. Cardiol.41, A292 (2003).
   Google Scholar
• Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol.288, R1220–R1225 (2005).
   PubMed Web of Science ®Google Scholar
• Hertzel A, Smith L, Berg A et al. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am. J. Physiol. Endocrinol. Metab.290, E814–E823 (2006).
   PubMed Web of Science ®Google Scholar
• Damcott CM, Moffett SP, Feingold E et al. Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor γ interactively influence insulin sensitivity and body composition in males. Metabolism53, 303–309 (2004).
   PubMed Web of Science ®Google Scholar
• Tuncman G, Erbay E, Hom X et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, Type 2 diabetes, and cardiovascular disease. Proc. Natl Acad. Sci. USA 103, 6970–6975 (2006).
   PubMed Web of Science ®Google Scholar
• Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and Type 2 diabetes. Nature436, 356–362 (2005).
   PubMed Web of Science ®Google Scholar
• Graham TE, Yang Q, Bluher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med.354, 2552–2563 (2006).
   PubMed Web of Science ®Google Scholar